Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Wiebke Arlt(University of Birmingham), Martín Reincke(LMU Klinikum), Christian Adolf(LMU Klinikum), Felix Beuschlein(University of Zurich), Vasileios Chortis(Boston Children's Hospital), Lorna C Gilligan(University College Birmingham), Anna Dietz(Ludwig-Maximilians-Universität München), Yara Rhayem(Ludwig-Maximilians-Universität München), Donna O’Neil(University of Birmingham), Irina Bancos(Mayo Clinic in Arizona), Annette Feuchtinger(Helmholtz Zentrum München), Stefanie Hahner(University of Würzburg), Tanja Dekkers(Radboud University Nijmegen), Martin Bidlingmaier(LMU Klinikum), Katharina Lang(University of Birmingham), Brian Keevil(University of Manchester), Zaki Hassan‐Smith(University Hospitals Birmingham NHS Foundation Trust), Anna Riester(Ludwig-Maximilians-Universität München), Alice Sitch(University of Birmingham), Axel Walch(Unknown), Jaap Deinum(Radboud University Nijmegen), Jeremy Tomlinson(Oxford Centre for Diabetes, Endocrinology and Metabolism), Michael Biehl(University of Groningen), Marcus Quinkler(Charité - Universitätsmedizin Berlin), Aled Rees(University of Wales), Evelyn Asbach(Ludwig-Maximilians-Universität München), Beverly Hughes(University of Birmingham), Philippe Ludwig(Ludwig-Maximilians-Universität München), Cedric Shackleton(UCSF Benioff Children's Hospital), Jonathan J Deeks(Birmingham City University)
Cited by 275
Related Papers
Evaluating non-randomised intervention studies
|Health Technology Assessment|2003|2.9k
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863